<DOC>
	<DOCNO>NCT00549575</DOCNO>
	<brief_summary>Although strong rationale supplement gravid patient suffer intrauterine growth restriction ( IUGR ) preeclampsia Arginine nitric oxide donor , evidence literature inconclusive . The current study design determine whether oral treatment L-Arginine , nitric oxide ( NO ) donor , would enhance birth weight and/or decrease neonatal morbidity pregnancy severe vascular intrauterine growth restriction ( IUGR ) .</brief_summary>
	<brief_title>L-Arginine Treatment Severe Vascular Fetal Intrauterine Growth Restriction : Randomized Double Bind Controlled Trial ( L Arginine IUGR )</brief_title>
	<detailed_description>Patients Methods : 44 patient singleton pregnancy refer IUGR detect ultrasonic examination include . Vascular IUGR define fetal abdominal circumference less equal third percentile , associate abnormal uterine Doppler . After double blind randomization , patient receive either 14 g/day L-arginine ( 90 mL syrup , Veyron France Laboratories ) , placebo . Doppler ultrasound examination uterine , umbilical cerebral circulation , ductus venosus perform prior inclusion , 7 day treatment , day delivery . Ultrasound examination perform upon randomization , weekly birth . Venous blood urine sample collect initiation 7 day treatment , maternal umbilical venous sample obtain delivery nitrate nitrite ( NO2-/ NO3- ) determination .</detailed_description>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<criteria>Multicenter randomize trial . Patients singleton pregnancy IUGR define fetal abdominal circumference less equal third percentile gestational age , abnormal uterine Doppler . Uterine Doppler consider pathologic Pourcelot 's resistance index ( SD/S ) equal high 0.7 , and/or obvious notch present . If placenta median , side pathologic Doppler side placenta Acute fetal distress Non vascular non severe IUGR ( normal uterine doppler scan and/or abdominal circumference &gt; 3rd percentile ) Maternal immune disorder IUGR infectious etiology IUGR associate fetal malformation , multifetal pregnancy , preeclampsia upon inclusion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Severe Intra uterine growth retardation third centile abnormal uterine doppler</keyword>
	<keyword>Severe growth retardation pathologic uterine Doppler</keyword>
	<keyword>L-Arginine</keyword>
	<keyword>Nitric Oxide Donor</keyword>
</DOC>